 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
EDITORIAL COMMENT
Minerva Urology and Nephrology 2021 October;73(5):674-6
DOI: 10.23736/S2724-6051.21.04762-5
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English
Is there enough evidence available nowadays to suggest a paradigmatic shift in treatment of MIBC with perioperative systemic therapy administration?
Francesco DEL GIUDICE 1, 2 ✉, David D’ANDREA 3, Andrea MARI 4, Francesco SORIA 5, Wojciech KRAJEWSKI 6, Marco MOSCHINI 7, on behalf of the YAU Urothelial Working Group
| ACCESS OPTIONS | |
|
You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of € 10,00. Downloading and printing for personal use allowed. Access as an individual subscriber Access through your institution |
Subscribe to Minerva Urology and Nephrology |
Institutional access